Meetings

FDA approves expedited development/review of the drug Esketamine

A pharmaceutical company announced Tuesday that the Food and Drug Administration has approved expedited development and review of the drug esketamine, commonly called ketamine, in treating major depression. Ketamine has been approved as an anesthetic for humans and animals and is one of the most popular painkillers for children in emergency rooms across the country. It’s also popular as both a party … Read more…

%d bloggers like this: